GC
EW icon

Grace Capital’s Edwards Lifesciences EW Stock Holding History

Grace Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$484K Buy
3,738
+207
+6% +$24.1K 0.29% 96
2021
Q3 		$400K Buy
3,531
+155
+5% +$17.7K 0.25% 111
2021
Q2 		$350K Buy
3,376
+260
+8% +$24.5K 0.23% 107
2021
Q1 		$261K Buy
3,116
+58
+2% +$4.9K 0.17% 135
2020
Q4 		$279K Sell
3,058
-410
-12% -$34K 0.18% 127
2020
Q3 		$277K Buy
3,468
+258
+8% +$20.1K 0.21% 105
2020
Q2 		$222K Buy
+3,210
New +$228K 0.19% 113
2020
Q1 		– Sell
-3,189
Closed -$248K – 187
2019
Q4 		$248K Buy
+3,189
New +$249K 0.2% 115
2019
Q3 		– Sell
-26,070
Closed -$1.6M – 150
2019
Q2 		$1.6M Sell
26,070
-13,494
-34% -$816K 0.77% 41
2019
Q1 		$2.52M Sell
39,564
-2,046
-5% -$117K 0.98% 26
2018
Q4 		$2.12M Sell
41,610
-5,124
-11% -$259K 0.99% 27
2018
Q3 		$2.71M Sell
46,734
-4,440
-9% -$217K 1.06% 29
2018
Q2 		$2.48M Buy
+51,174
New +$2.39M 0.95% 33

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grace Capital's EW Position: Q4 2021 in Review

Grace Capital increased its Edwards Lifesciences (EW) stake by 5.9% in Q4 2021, buying an estimated $24.1K and bringing the position to 3,738 shares worth $484K. The position accounts for 0.29% of the portfolio, ranked #96.

Grace Capital first reported a position in EW in Q2 2018 and has held it in 13 quarters since. The position peaked at $2.71M in Q3 2018. 1,320 funds tracked by Wall St. Rank hold EW as of Q4 2021.

  • Grace Capital held 3,738 shares of Edwards Lifesciences worth $484K as of Q4 2021.
  • Grace Capital bought 207 Edwards Lifesciences shares in Q4 2021, an estimated $24.1K.
  • Edwards Lifesciences made up 0.29% of Grace Capital's portfolio in Q4 2021, its #96 holding.
  • Grace Capital first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 13 quarters since.
  • Grace Capital's Edwards Lifesciences position peaked at $2.71M in Q3 2018.
  • 1,320 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.